by | May 13, 2025 | Haller, Gabriel, Li, Chengcheng, Weihl, Conrad
— Published Date: 5/14/2025
Value Proposition: Method that uses gene-therapy to detect limb-girdle muscular dystrophy (LGMD) type 4R/2E.
Technology Description
Researchers at Washington University in St. Louis have developed a method of predicting limb-girdle muscular dystrophy (LGMD) type 4R/2…
by | Jun 11, 2024 | Banas, Victoria, Janetka, James, Mahoney, Matthew, Mitreva, Makedonka
— Novel Composition Designed to Treat Nematode Infections
Value proposition: Small molecule treatments designed to target the adult worm to treat nematode infections in animals.
Technology Description
Researchers at Washington University in St. Louis have developed novel small molecule treatment…
by | May 15, 2024 | Aleem, Alexander, Ilagan, Maxenia, McCoy IV, William
— Value Proposition: This invention uses antibodies to detect Cutibacterium acnes (C. acnes) infections.
Technology Description
Researchers at Washington University in St. Louis have developed antibodies that can identify Cutibacterium acnes (C. acnes), which opportunistically causes infection rang…
by | Oct 22, 2019 | Clark, Amy, Mahadevan, Jana, Urano, Fumihiko
— Technology Description
Dr. Fumihiko Urano at Washington University in St. Louis (WUSTL) and colleagues have developed therapeutic strategies to treat Wolfram syndrome. Wolfram syndrome is a rare, life-threating, genetic disorder characterized by insulin-dependent diabetes mellitus, diabetes insipi…
by | Mar 10, 2018 | Anastasaki, Corina, Gutmann, David
— Background: Neurofibromatosis type 1 (NF1) is a common neurological condition affecting roughly 1 in every 2,500 individuals. NF1 is associated with a host of clinical presentations, including malignant tumors and cognitive defects ranging from attention deficits, mental retardation, and autism. The…